Drug recall · August 25, 2021
Tizanidine HCl Tablets recall
Why: Failed Tablet/Capsule Specification: Some tablets are shaved
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Tizanidine HCl Tablets, USP 4 mg, 150-count bottles, Rx only, Mfd By: Dr. Reddy's Laboratories limited, Srikakulam District, 532 409 INDIA, NDC 55111-180-15.
- Lots / codes
Lot #: T2000471, exp date 09/2023
- Quantity
- 37560 bottles
- Company
- Dr. Reddy's Laboratories, Inc., Princeton, NJ
- Distribution
- Nationwide within the United States
- Initiated
- July 19, 2021 · Voluntary: Firm initiated
- Classified
- August 18, 2021
- Reported
- August 25, 2021
- Ended
- December 21, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tizanidine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.